We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTI icon
1976
W&T Offshore
WTI
$475M
$418K ﹤0.01%
+157,712
New +$451K
RDNW
1977
RideNow Group
RDNW
$252M
$417K ﹤0.01%
+64,585
New +$450K
KNTE
1978
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$415K ﹤0.01%
156,089
-38,379
-20% -$95K
TIPT icon
1979
Tiptree Inc
TIPT
$688M
$414K ﹤0.01%
+23,977
New +$430K
DCTH icon
1980
Delcath Systems
DCTH
$404M
$413K ﹤0.01%
86,665
-43,760
-34% -$189K
TWIN icon
1981
Twin Disc
TWIN
$332M
$411K ﹤0.01%
+24,885
New +$390K
NVCT icon
1982
Nuvectis Pharma
NVCT
$613M
$411K ﹤0.01%
50,068
+25,255
+102% +$215K
IMMR icon
1983
Immersion
IMMR
$254M
$409K ﹤0.01%
+54,716
New +$389K
CORZ icon
1984
Core Scientific
CORZ
$6.52B
$409K ﹤0.01%
+115,598
New +$401K
BLTE
1985
Belite Bio
BLTE
$6.23B
$406K ﹤0.01%
10,584
-5,427
-34% -$243K
AFL icon
1986
Aflac
AFL
$65.7B
$406K ﹤0.01%
4,728
-14,937
-76% -$1.22M
FLYX.WS icon
1987
CALL
flyExclusive Inc Warrants
FLYX.WS
$406K ﹤0.01%
70,594
-29,677
-30% -$14.1K
MT icon
1988
ArcelorMittal
MT
$50.6B
$403K ﹤0.01%
14,611
-789,033
-98% -$21.3M
ARR
1989
Armour Residential REIT
ARR
$2.02B
$402K ﹤0.01%
+20,352
New +$391K
ADAP
1990
DELISTED
Adaptimmune Therapeutics
ADAP
$401K ﹤0.01%
+254,013
New +$307K
NIOBW
1991
CALL
NioCorp Developments Ltd Warrant
NIOBW
$48.1M
$400K ﹤0.01%
168,226
-17,358
-9% -$7.64K
LNT icon
1992
Alliant Energy
LNT
$19.2B
$398K ﹤0.01%
+7,900
New +$387K
ECXWW
1993
CALL
ECARX Holdings Warrants
ECXWW
$396K ﹤0.01%
240,000
-10,000
-4% -$255
JSPR icon
1994
Jasper Therapeutics
JSPR
$20.1M
$395K ﹤0.01%
+13,449
New +$239K
GERN icon
1995
Geron
GERN
$937M
$394K ﹤0.01%
119,500
-1,958,997
-94% -$4.39M
SSNC icon
1996
SS&C Technologies
SSNC
$18.7B
$394K ﹤0.01%
6,123
-51,625
-89% -$3.21M
LNKB
1997
DELISTED
LINKBANCORP
LNKB
$394K ﹤0.01%
+56,767
New +$409K
CVX icon
1998
CALL
Chevron
CVX
$375B
$393K ﹤0.01%
2,400
-28,400
-92% -$4.29M
DSX icon
1999
Diana Shipping
DSX
$270M
$392K ﹤0.01%
135,572
-13,021
-9% -$38.8K
COPX icon
2000
Global X Copper Miners ETF NEW
COPX
$7.06B
$390K ﹤0.01%
+9,200
New +$342K

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.